EFFECT OF LIPOPOLYSACCHARIDE ON MITOGEN-ACTIVATED PROTEIN-KINASES AND CYTOSOLIC PHOSPHOLIPASE A(2)

被引:51
|
作者
FOUDA, SI
MOLSKI, TFP
ASHOUR, MSE
SHAAFI, RI
机构
[1] AL-AZHAR UNIV,SCH PHARM,DEPT MICROBIOL,CAIRO,EGYPT
[2] UNIV CONNECTICUT,CTR HLTH,DEPT PHYSIOL,FARMINGTON,CT 06030
关键词
D O I
10.1042/bj3080815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The addition of platelet-activating factor (PAF) to human neutrophils increases phosphorylation on tyrosine residues and stimulates the activity of p42(erk2)mitogen-activated protein kinase (MAP kinase). This action is rapid and transient. In contrast, p42(erk2), p44(erk1) and the p40(hera) MAP kinase isoforms are all not tyrosine phosphorylated or activated in human neutrophils stimulated with low concentrations of lipopolysaccharide (LPS) in combination with serum. In spite of this, the PAF-induced tyrosine phosphorylation and activation of the p42(erk2) MAP kinase are greatly potentiated in cells pretreated with LPS. More interestingly, although low concentrations of LPS do not affect MAP kinase isoforms in these cells, they cause the phosphorylation of cytosolic phospholipase A(2) (cPLA(2)), as evidenced by a decrease in the electrophoretic mobility of the enzyme. In addition, this stimulus-induced upward shift in the mobility of the enzyme is not inhibited by the tyrosine kinase inhibitor, genistein. Furthermore, LPS increases the release of arachidonic acid in control and PAF-stimulated human neutrophils. These observations clearly show that cPLA(2) can be phosphorylated and activated by kinases other than the currently known MAP kinases. It is proposed that there are MAP kinase-dependent and -independent mechanisms for the phosphorylation of cPLA(2).
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
  • [31] Mitogen-activated protein kinases in innate immunity
    Arthur, J. Simon C.
    Ley, Steven C.
    NATURE REVIEWS IMMUNOLOGY, 2013, 13 (09) : 679 - 692
  • [32] Thrombomodulin Regulation of Mitogen-Activated Protein Kinases
    Giri, Hemant
    Cai, Xiaofeng
    Panicker, Sumith R.
    Biswas, Indranil
    Rezaie, Alireza R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [33] Mitogen-activated protein kinases and cerebral ischemia
    Kazuhiko Nozaki
    Masaki Nishimura
    Nobuo Hashimoto
    Molecular Neurobiology, 2001, 23 : 1 - 19
  • [34] Mitogen-activated protein kinases in innate immunity
    J. Simon C. Arthur
    Steven C. Ley
    Nature Reviews Immunology, 2013, 13 : 679 - 692
  • [35] Mitogen-activated protein kinases in endothelial pathophysiology
    Bogatcheva, NV
    Dudek, SM
    Garcia, JGN
    Verin, AD
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 (06) : 341 - 352
  • [36] Mitogen-activated protein kinases in apoptosis regulation
    Teiji Wada
    Josef M Penninger
    Oncogene, 2004, 23 : 2838 - 2849
  • [37] Targeting mitogen-activated protein kinases for asthma
    Duan, Wei
    Wong, W. S. Fred
    CURRENT DRUG TARGETS, 2006, 7 (06) : 691 - 698
  • [38] Mitogen-activated protein kinases and septic cardiomyopathy
    Zetoune, Firas S.
    Hoesel, Laszlo M.
    Neiderbichler, Andreas D.
    Flierl, Michael A.
    Rittirsch, Daniel
    Nadeau, Brian
    Sarma, J. Vidya
    Ward, Peter A.
    FASEB JOURNAL, 2007, 21 (06): : A1150 - A1150
  • [39] Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1
    Hernández, M
    Burillo, SL
    Crespo, MS
    Nieto, ML
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 606 - 612
  • [40] Activation of mitogen-activated protein kinases in oligodendrocytes
    Bhat, NR
    Zhang, PS
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (05) : 1986 - 1994